ProPhase Labs PRPH January 2021 Investor Presentation

ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company offering OTC consumer healthcare products, dietary supplements (TK Supplements), and COVID-19 testing services through its subsidiary ProPhase Diagnostics. The company targets 60,000 daily test capacity by Q1 2021 and reported 40% year-over-year revenue growth in the first nine months of 2020.